Enliven Therapeutics Inc ELVN

$46.97 +0.76 (1.64%)

Valuation

Market cap
3,385,853,000
Revenue TTM
$0
Net income TTM
$-103,690,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
1,123,200
Avg volume
1,190,358
Day's range
$45.92 – $47.43
Shares out
73,271,000
Stochastic %K
56%
Beta
0.24
Analysts
Strong Sell
Price target
$72.75

Price

Company profile

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal gro...

Show more

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.

Industry
Biotechnology
Sector
Healthcare
Phone
720 647 8519
Website
https://www.enliventherapeutics.com
Address
6200 Lookout Road, Boulder, United States

Latest news

Stocktwits

thedentite Sep 16, 6:02 PM
$ELVN Am I missing something?
1 replies
mktrdr59 Sep 1, 1:26 AM
$ELVN could be completing three wave corrective pattern that looks like a bull flag.
0 replies
thedentite Aug 28, 10:15 PM
$ELVN Damn I thought I got the bottom. Well, 200 more shares at 58,18. Monday it’ll be 61
0 replies
StockConsultant Aug 25, 2:47 AM
$ELVN Enliven Therapeutics stock, watch for a top of range breakout at https://www.stockconsultant.com/?ELVN Breakout trade WATCH for possible breakout above 61.68 Target: 69.61, 13.8% Stop: 58.67 Loss: 4.1% P/L ratio: 3.4 : 1 - Excellent BULLISH [Timing] Strong bullish 3 day candlestick pattern with Average 3 day accumulation. [Timing] Strong bullish 1 day moneyflow [Timing] breakout watch above 61.68, no resistance in area just above. BEARISH [Positioning] Intermediate trend bearish, Unsustainable uptrend, may turn sideways. [Positioning] at resistance
0 replies
thedentite Aug 20, 7:10 PM
$ELVN Ending green?
0 replies
anachartanalyst Aug 18, 12:01 PM
$ELVN https://anachart.com/wp-content/uploads/2026/08/1787054473_soc-img.jpg
0 replies
Quantumup Aug 18, 11:15 AM
Barclays🏁Enliven Therapeutics: Overweight-$78 $NVS TERN - $MRK William Blair🏁 $ELVN at Outperform Here's what Barclays and William Blair said in their initiation reports: https://x.com/Quantumup1/status/2089672206288626089?s=20
0 replies
thedentite Aug 17, 8:11 PM
$ELVN That's a nice finish.
0 replies